Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective

Current Problems of Psychiatry Pub Date : 2021-06-01 DOI:10.2478/cpp-2021-0008

D. Blat, E. Stelmach

{"title":"Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective","authors":"D. Blat, E. Stelmach","doi":"10.2478/cpp-2021-0008","DOIUrl":null,"url":null,"abstract":"Abstract Introduction: Cardiovascular diseases, especially coronary heart disease or heart failure, are often chronic. Aim and method: The aim of this study was to review the literature on the prevalence of depressive disorders and the use of antidepressants in cardiovascular disease. For this purpose, articles available in PubMed and Google Scholar databases were used. Results: About one in five patients with cardiovascular disease suffers from major depressive disorder. Psychosocial stress, depression and anxiety, are associated with poorer prognosis and make it more difficult for patients to make positive lifestyle changes and comply with medical recommendations. Conversely, depressive symptoms are associated with an increased risk of cardiovascular incidents. Regarding pharmacotherapy, selective serotonin reuptake inhibitors (SSRIs) are considered safe drugs, while tricyclic antidepressants are not recommended. In the treatment of depression and cardiovascular diseases, supplementation or a diet rich in omega-3 fatty acids is worth mentioning. Conclusions: The above literature review highlights the need for a multidirectional approach that is essential to diagnose, understand and then treat these, often comorbid, conditions of cardiovascular disease and depression.","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"44 1","pages":"87 - 93"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Problems of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/cpp-2021-0008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract Introduction: Cardiovascular diseases, especially coronary heart disease or heart failure, are often chronic. Aim and method: The aim of this study was to review the literature on the prevalence of depressive disorders and the use of antidepressants in cardiovascular disease. For this purpose, articles available in PubMed and Google Scholar databases were used. Results: About one in five patients with cardiovascular disease suffers from major depressive disorder. Psychosocial stress, depression and anxiety, are associated with poorer prognosis and make it more difficult for patients to make positive lifestyle changes and comply with medical recommendations. Conversely, depressive symptoms are associated with an increased risk of cardiovascular incidents. Regarding pharmacotherapy, selective serotonin reuptake inhibitors (SSRIs) are considered safe drugs, while tricyclic antidepressants are not recommended. In the treatment of depression and cardiovascular diseases, supplementation or a diet rich in omega-3 fatty acids is worth mentioning. Conclusions: The above literature review highlights the need for a multidirectional approach that is essential to diagnose, understand and then treat these, often comorbid, conditions of cardiovascular disease and depression.

查看原文本刊更多论文

从心脏病专家的角度来看，抑郁症和抗抑郁药在心血管疾病中的使用

摘要导读:心血管疾病，尤其是冠心病或心力衰竭，往往是慢性的。目的和方法:本研究的目的是回顾有关抑郁症患病率和抗抑郁药在心血管疾病中的应用的文献。为此，我们使用了PubMed和Google Scholar数据库中的文章。结果:大约五分之一的心血管疾病患者患有重度抑郁症。心理社会压力、抑郁和焦虑与预后较差有关，并使患者更难以积极改变生活方式和遵守医疗建议。相反，抑郁症状与心血管事件的风险增加有关。在药物治疗方面，选择性5 -羟色胺再摄取抑制剂(SSRIs)被认为是安全的药物，而三环抗抑郁药不推荐使用。在抑郁症和心血管疾病的治疗中，补充或饮食中富含omega-3脂肪酸是值得一提的。结论:上述文献综述强调了多方向方法的必要性，这对于诊断、理解和治疗这些心血管疾病和抑郁症的合并症至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Problems of Psychiatry

自引率

0.00%

发文量

审稿时长

15 weeks

期刊介绍： The quarterly Current Problems of Psychiatry is a continuation of the volume "Research on Schizophrenia" and is addressed to a wide group of psychiatrists and clinical psychologists. The quarterly is a reviewed scientific journal of international scope, publishing original papers, review papers, case studies, conference reports, letters to the editor and book reviews. The aim of the "Current Problems of Psychiatry" is providing a wide audience with scientific works, representing a significant contribution to the development of psychiatry and clinical psychology. The works published in the journal are printed in Polish and English. Terms and Conditions for publishing manuscripts in the quarterly are available on the website www.cppsych.umlub.pl in the tab "Requirements".